Jaguar Health, Inc. JAGX
NASDAQ
Recommendation
Dividend Power Score
Day's Range
$2.06$2.24
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 135.31% | 155.75% | -1.52% | 12.45% | 15.95% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 135.52% | 155.96% | -1.52% | 12.45% | 15.95% |
| Cost of Revenue | 129.95% | 116.52% | 93.04% | 2.21% | 3.98% |
| Gross Profit | 136.75% | 164.42% | -20.52% | 15.00% | 18.99% |
| SG&A Expenses | -15.55% | -0.38% | 16.05% | 19.78% | 22.46% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.48% | 26.35% | 33.16% | 10.58% | 7.43% |
| Operating Income | 23.60% | 20.39% | -46.31% | -9.92% | -4.66% |
| Income Before Tax | 10.84% | 14.33% | -37.57% | -7.08% | -14.37% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 10.84% | 14.33% | -37.57% | -7.08% | -14.37% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -31.59% | -25.63% | -25.82% | 27.57% | 41.07% |
| Net Income | 10.45% | 14.12% | -38.82% | -6.76% | -13.96% |
| EBIT | 23.60% | 20.39% | -46.31% | -9.92% | -4.66% |
| EBITDA | 25.03% | 21.75% | -49.30% | -10.64% | -5.12% |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | -- | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | -- | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |